TALEN

TALEN1-smyhc1,smyhc2,smyhc3

ID
ZDB-TALEN-210902-1
Name
TALEN1-smyhc1,smyhc2,smyhc3
Previous Names
None
Targets
Target Sequence 1
5' - TGAGGTCAACTCACCCTC - 3'
Target Sequence 2
5' - CTTAGTCTCATTGGGGATCA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
stl582 smyhc1
stl584 smyhc1
Expression
Gene expression in Wild Types + TALEN1-smyhc1,smyhc2,smyhc3
No data available
Phenotype
Phenotype resulting from TALEN1-smyhc1,smyhc2,smyhc3
No data available
Phenotype of all Fish created by or utilizing TALEN1-smyhc1,smyhc2,smyhc3
Phenotype Fish Conditions Figures
post-vent region kinked, abnormal smyhc1stl582/stl582 standard conditions Figure 4 with image from Whittle et al., 2020
slow muscle cell disorganized, abnormal smyhc1stl582/stl582 standard conditions Figure 6 with image from Whittle et al., 2020
muscle cell ab-f59 labeling absent, abnormal smyhc1stl582/stl582 standard conditions Figure 1 with image from Whittle et al., 2020
trunk kinked, abnormal smyhc1stl582/stl582 standard conditions Figure 4 with image from Whittle et al., 2020
vertebral column kinked, abnormal smyhc1stl582/stl582 standard conditions Figure 4 with image from Whittle et al., 2020
slow muscle cell Z disc ab1-actn labeling absent, abnormal smyhc1stl582/stl582 standard conditions Figure 6 with image from Whittle et al., 2020
whole organism decreased life span, abnormal smyhc1stl582/stl582 standard conditions Figure 3 with image from Whittle et al., 2020
whole organism dead, abnormal smyhc1stl582/stl582 standard conditions Figure 3 with image from Whittle et al., 2020
whole organism paralysed, abnormal smyhc1stl582/stl582 standard conditions Figure 2 with image from Whittle et al., 2020
slow muscle cell actin filament punctate, abnormal smyhc1stl582/stl582 standard conditions Figure 6 with image from Whittle et al., 2020
slow muscle cell shape, abnormal smyhc1stl582/stl582 standard conditions Figure 6 with image from Whittle et al., 2020
slow muscle cell Z disc absent, abnormal smyhc1stl582/stl582 standard conditions Figure 6 with image from Whittle et al., 2020
post-vent region curved dorsal, abnormal smyhc1stl582/stl582 standard conditions Figure 4 with image from Whittle et al., 2020
whole organism ab-f59 labeling absent, abnormal smyhc1stl582/stl582 standard conditions Figure 1 with image from Whittle et al., 2020
slow muscle cell Z disc ab1-actn labeling spatial pattern, abnormal smyhc1stl582/stl582 standard conditions Figure 6 with image from Whittle et al., 2020
motor behavior decreased process quality, abnormal smyhc1stl582/stl582 standard conditions Figure 5 with image from Whittle et al., 2020
post-vent region kinked, abnormal smyhc1stl584/stl584 control Figure 2 with imageFigure 7 with image from Whittle et al., 2020
slow muscle cell disorganized, abnormal smyhc1stl584/stl584 standard conditions Figure 6 with image from Whittle et al., 2020
trunk kinked, abnormal smyhc1stl584/stl584 control Figure 2 with imageFigure 7 with image from Whittle et al., 2020
trunk shape, ameliorated smyhc1stl584/stl584 chemical treatment: blebbistatin Figure 7 with image from Whittle et al., 2020
somite decreased length, abnormal smyhc1stl584/stl584 standard conditions Figure 6 with image from Whittle et al., 2020
post-vent region shape, ameliorated smyhc1stl584/stl584 chemical treatment: blebbistatin Figure 7 with image from Whittle et al., 2020
myotome decreased length, abnormal smyhc1stl584/stl584 standard conditions Figure 6 with image from Whittle et al., 2020
notochord kinked, abnormal smyhc1stl584/stl584 standard conditions Figure 2 with image from Whittle et al., 2020
pericardium edematous, abnormal smyhc1stl584/stl584 chemical treatment: blebbistatin Figure 7 with image from Whittle et al., 2020
slow muscle cell actin filament punctate, abnormal smyhc1stl584/stl584 standard conditions Figure 6 with image from Whittle et al., 2020
slow muscle cell shape, abnormal smyhc1stl584/stl584 standard conditions Figure 6 with image from Whittle et al., 2020
slow muscle cell Z disc ab1-actn labeling spatial pattern, abnormal smyhc1stl584/stl584 standard conditions Figure 6 with image from Whittle et al., 2020
slow muscle cell Z disc disorganized, abnormal smyhc1stl584/stl584 standard conditions Figure 6 with image from Whittle et al., 2020
post-vent region curved dorsal, abnormal smyhc1stl584/stl584 chemical treatment: blebbistatin Figure 7 with image from Whittle et al., 2020
post-vent region kinked, abnormal smyhc1stl584/+ control Figure 4 with imageFigure 7 with image from Whittle et al., 2020
slow muscle cell disorganized, abnormal smyhc1stl584/+ standard conditions Figure 6 with image from Whittle et al., 2020
trunk kinked, abnormal smyhc1stl584/+ control Figure 4 with imageFigure 7 with image from Whittle et al., 2020
trunk shape, ameliorated smyhc1stl584/+ chemical treatment: blebbistatin Figure 7 with image from Whittle et al., 2020
post-vent region shape, ameliorated smyhc1stl584/+ chemical treatment: blebbistatin Figure 7 with image from Whittle et al., 2020
vertebral column kinked, abnormal smyhc1stl584/+ standard conditions Figure 4 with image from Whittle et al., 2020
myotome decreased length, abnormal smyhc1stl584/+ standard conditions Figure 6 with image from Whittle et al., 2020
notochord kinked, abnormal smyhc1stl584/+ standard conditions Figure 2 with image from Whittle et al., 2020
whole organism decreased life span, abnormal smyhc1stl584/+ standard conditions Figure 3 with image from Whittle et al., 2020
pericardium edematous, abnormal smyhc1stl584/+ chemical treatment: blebbistatin Figure 7 with image from Whittle et al., 2020
whole organism dead, abnormal smyhc1stl584/+ standard conditions Figure 3 with image from Whittle et al., 2020
slow muscle cell actin filament punctate, abnormal smyhc1stl584/+ standard conditions Figure 6 with image from Whittle et al., 2020
slow muscle cell shape, abnormal smyhc1stl584/+ standard conditions Figure 6 with image from Whittle et al., 2020
post-vent region curved dorsal, abnormal smyhc1stl584/+ standard conditions Figure 4 with image from Whittle et al., 2020
somite decreased length, abnormal smyhc1stl584/+ standard conditions Figure 6 with image from Whittle et al., 2020
post-vent region curved dorsal, abnormal smyhc1stl584/+ chemical treatment: blebbistatin Figure 7 with image from Whittle et al., 2020
motor behavior decreased process quality, abnormal smyhc1stl584/+ standard conditions Figure 5 with image from Whittle et al., 2020
trunk kinked, abnormal smyhc1stl584/+; smyhc1stl582/+ standard conditions Figure 2 with image from Whittle et al., 2020
post-vent region kinked, abnormal smyhc1stl584/+; smyhc1stl582/+ standard conditions Figure 2 with image from Whittle et al., 2020
notochord kinked, abnormal smyhc1stl584/+; smyhc1stl582/+ standard conditions Figure 2 with image from Whittle et al., 2020
Citations